Product Images Sildenafil Citrate

This text appears to be a chart showing estimated cumulative mortality rates at different doses over time. The doses are labeled as high dose, medium dose, and low dose, with corresponding percentages of estimated cumulative mortality rates given for each dose at different time intervals. However, the chart seems incomplete and lacks information to provide a full context.*

This appears to be a drug interaction chart showing the fold change in drugs and the recommended dose adjustments with a 90% confidence interval. It includes drugs like Atorvastatin, Adithromyein, Bosentan, Cimetidine, Mes, Erymromycin, Maslox, Oral Contraceptives, Rioravir, and Saquinavir. The chart also notes that co-administration of Rioravir with Sildenafil is not recommended. Additionally, there is a note about exercise capacity and the combination of Bosentan and Sildenafil in clinical studies.*

This text appears to be a list of drugs and their interactions with Acenocoumarol. The text provides information about the effect of these drugs on the INR AUC and Cmax values, as well as any necessary dose adjustments. The text also lists Tolbutamide as one of the interacting drugs but does not indicate any effect on INR values or dose adjustments. The last line mentions a clinical study that found no benefit on exercise capacity when Sidonati is added to Bosantan therapy.*

This is a table with the "Change from Baseline" values in meters for a clinical study conducted over 12 weeks. The study compared the effectiveness of different doses of Sildenafil (20mg, 40mg, and 80mg taken three times a day) against a placebo in an unrevealed condition. The table lacks clarity and context, and apparently, the software did not identify some visible character/symbol on the Week 4 column header.*

The text is describing a clinical study of idiopathic PAH with the use of Placebo and Sildenafil 20 mg TID. It includes baseline walk distance and criteria for function capacity. There is also information about the gender and age of patients, as well as Median PAP in mmHg. The placebo-corrected change in 6-Minute Walk Distance (m) is plotted on a graph.*

The given text is a description of a graph labeled as "Figure 12", related to 'Sildenafil Protocol A1481244'. The graph displays the mean change (in meters) from baseline for a Six Minute Walk Test for different doses of sildenafil (1mg TID, 5mg TID, and 20mg TID) up to the 12th week. The graph shows the standard error as well.*

This text describes a pharmaceutical product called Sildenafil. Each film-coated tablet includes 20 g of sildenafil citrate USP, and they should be stored at temperatures between 15°C and 30°C in a tightly closed container with a child-resistant closure. The usual dosage and prescribing information should be followed, and a Patient Information Sheet should be provided to each patient. The product is manufactured by Torrent Pharmaceuticals LTD in India and is distributed by Torrent Pharma Inc. in Levitiown, PA.*